Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities



Rating:

Share or cite this content

Citations should be made in the following way:
Yuksel Peker (Istanbul, Turkey). Obstructive sleep apnoea and coronary artery disease. International Congress 2016 – PG18 Sleep apnoea and comorbidities

Member's Comments

No comment yet.

Related content which might interest you: Influence of obstructive sleep apnea in coronary artery disease: an 8-years-follow-up Source: Eur Respir J 2003; 22: Suppl. 45, 22s Year: 2003 Association between obstructive sleep apnea syndrome and coronary atherosclerostic disease Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Changes in extracranial arteries in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 69-74 Year: 2005 Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017 Year: 2017 Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018 Undiagnosed COPD and overlapping obstructive sleep apnoea in coronary heart disease Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Heart rate turbulence: In patients with obstructive sleep apnea without coronary artery diseases Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA). Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea Year: 2017 Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up Source: Eur Respir J 2006; 28: 596-602 Year: 2006 Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Obstructive sleep apnoea in acute coronary syndrome: the invisible threat? Source: Eur Respir J , 49 (3) 1602539; DOI: 10.1183/13993003.02539-2016 Year: 2017 Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013 Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders Year: 2020 Increased incidence of coronary artery disease in obstructive sleep apnoea: a seven-year follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001 Obstructive sleep apnoea and heart failure Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities Year: 2016 Obstructive sleep apnea can cause pulmonary hypertension in the absence of lung disease Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004 Obstructive sleep apnea and prognosis in acute pulmonary embolism Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020